Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R

Healthcare Biotechnology


TSX:CXR.R - Post by User

Concordia Healthcare Corp. > Andrew McCreath - BNN
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by ChartSchoolon Dec 09, 2015 11:07am
120 Views
Post# 24368948

RE:RE:RE:RE:RE:Andrew McCreath - BNN

RE:RE:RE:RE:RE:Andrew McCreath - BNN

fdfd12 wrote:
I will say this, Andrew didn't like CXR when it was dropping. He said "watch out" from it.
Then he had the interview with CEO and changed his mind completley.

I also tweeted to him.
Here is a copy of my tweet on Oct 26


CXR guides $6.29 - $6.77US. Isn't it clear that a 15 multiple brings it to $95US despite the big debt? Why a brainer.

6:54 AM - 26 Oct 2015 · Details



Yikes, Herm. You realize that you just put out to everyone on this board your whole Twitter account. Not sure if you should have done this, and I fail to understand the relavance of your tweet to him from October 26th. Today he is a CXR fan, that's all we need to know.


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities